288 related articles for article (PubMed ID: 36831453)
1. Relationship between Tumor Budding and Partial Epithelial-Mesenchymal Transition in Head and Neck Cancer.
Okuyama K; Suzuki K; Yanamoto S
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831453
[TBL] [Abstract][Full Text] [Related]
2. The role of partial-EMT in the progression of head and neck squamous cell carcinoma.
Kisoda S; Mouri Y; Kitamura N; Yamamoto T; Miyoshi K; Kudo Y
J Oral Biosci; 2022 Jun; 64(2):176-182. PubMed ID: 35176487
[TBL] [Abstract][Full Text] [Related]
3. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
4. CYTOR Facilitates Formation of FOSL1 Phase Separation and Super Enhancers to Drive Metastasis of Tumor Budding Cells in Head and Neck Squamous Cell Carcinoma.
Wang W; Yun B; Hoyle RG; Ma Z; Zaman SU; Xiong G; Yi C; Xie N; Zhang M; Liu X; Bandyopadhyay D; Li J; Wang C
Adv Sci (Weinh); 2024 Jan; 11(4):e2305002. PubMed ID: 38032139
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.
Maffeis V; Cappellesso R; Galuppini F; Guzzardo V; Zanon A; Cazzador D; Emanuelli E; Ventura L; Martini A; Fassina A
Virchows Arch; 2020 Aug; 477(2):241-248. PubMed ID: 31980958
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tumor budding and its correlation with histomorphological prognostic markers in oral squamous cell carcinoma and its association with the epithelial-mesenchymal transition process.
Yadav K; Singh T; Varma K; Bhargava M; Misra V
Indian J Pathol Microbiol; 2023; 66(1):3-8. PubMed ID: 36656202
[TBL] [Abstract][Full Text] [Related]
7. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer.
Han L; Wang S; Wei C; Fang Y; Huang S; Yin T; Xiong B; Yang C
Expert Rev Mol Med; 2021 Nov; 23():e16. PubMed ID: 34758892
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
10. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment in head and neck squamous cell carcinoma.
Curry JM; Sprandio J; Cognetti D; Luginbuhl A; Bar-ad V; Pribitkin E; Tuluc M
Semin Oncol; 2014 Apr; 41(2):217-34. PubMed ID: 24787294
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma.
Huynh NC; Huang TT; Nguyen CT; Lin FK
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742914
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Microenvironment on Tumour Budding in Colorectal Cancer.
Georges LM; Verset L; Zlobec I; Demetter P; De Wever O
Adv Exp Med Biol; 2018; 1110():101-111. PubMed ID: 30623368
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic transition within the cancer microenvironment in early-stage oral tongue squamous cell carcinoma is associated with local recurrence.
Okuyama K; Suzuki K; Yanamoto S; Naruse T; Tsuchihashi H; Yamashita S; Umeda M
Int J Oncol; 2018 Oct; 53(4):1713-1720. PubMed ID: 30085337
[TBL] [Abstract][Full Text] [Related]
19. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
